Cardiac-restricted overexpression of the A2A-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A1-adenosine receptor

Clinical and Translational Science

Volumn 1, Issue 2, 2008, Pages 126-133

  Chan, Tung O ^a   Funakoshi, Hajime ^a   Song, Jianliang ^a   Zhang, Xue Qian ^a   Wang, Ju Fang ^a   Chung, Paul H ^a   DeGeorge Jr , Brent R ^a   Li, Xue ^a   Zhang, Jin ^a   Herrmann, David E ^a   Diamond, Maura ^a   Hamad, Eman ^a   Houser, Steven R ^b   Koch, Walter J ^a   Cheung, Joseph Y ^a   Feldman, Arthur M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine receptors; Ca2+ transients; Cardiac myocytes; Heart failure; Transgenic mice

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVITY; GENE OVEREXPRESSION; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HUMAN; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TRANSGENE;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CARDIOMYOPATHIES; HEART FAILURE; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; MICE; MICE, TRANSGENIC; MYOCARDIAL CONTRACTION; MYOCARDIUM; ORGAN SPECIFICITY; PHENOTYPE; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSGENES;

MUS; MUS MUSCULUS;

EID: 67651142624     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2008.00027.x     Document Type: Article

References (29)

1. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, Makitalo M, Jones MR, St Hilaire C, Seldin DC, Toselli P, Lamperti E, Schreiber BM, Gavras H, Wagner DD, Ravid K. The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest. 2006; 116(7): 1913-1923.
2. Klinger M, Freissmuth M, Nanoff C. Adenosine rec eptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal. 2002; 14(2): 99-108.
3. Norton GR, Woodiwiss AJ, McGinn RJ, Lorbar M, Chung ES, Honeyman TW, Fenton RA, Dobson JG Jr, Meyer TE. Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart. Am J Physiol. 1999; 276(2 Pt 2): H341-H349.
4. Cross HR, Murphy E, Black RG, Auchampach J, Steenbergen C. Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol. 2002; 283(4): H1562-H1568.
5. Yang Z, Cerniway RJ, Byford AM, Berr SS, French BA, Matherne GP. Cardiac overexpression of A1-adenosine receptor protects intact mice against myocardial infarction. Am J Physiol Heart Circ Physiol. 2002; 282(3): H949-H955.
6. Morrison RR, Jones R, Byford AM, Stell AR, Peart J, Headrick JP, Matherne GP. Transgenic overexpression of cardiac A(1) adenosine receptors mimics ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2000; 279(3): H1071-H1078.
7. Reichelt ME, Willems L, Molina JG, Sun CX, Noble JC, Ashton KJ, Schnermann J, Blackburn MR, Headrick JP. Genetic deletion of the A1 adenosine receptor limits myocardial ischemic tolerance. Circ Res. 2005; 96(3): 363-367.
8. Lankford AR, Yang JN, Rose'Meyer R, French BA, Matherne GP, Fredholm BB, Yang Z. Effect of modulating cardiac A1 adenosine receptor expression on protection with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2006; 290(4): H1469-H1473.
9. Funakoshi H, Chan TO, Good JC, Libonati JR, Piuhola J, Chen X, MacDonnell SM, Lee LL, Herrmann DE, Zhang J, Martini J, Palmer TM, Sanbe A, Robbins J, Houser SR, Koch WJ, Feldman AM. Regulated overexpression of the A1-adenosine receptor in mice results in adverse but reversible changes in cardiac morphology and function. Circulation. 2006; 114(21): 2240-2250.
10. Gauthier NS, Headrick JP, Matherne GP. Myocardial function in the working mouse heart overexpressing cardiac A1 adenosine receptors. J Mol Cell Cardiol. 1998; 30(1): 187-193.
11. Matherne GP, Linden J, Byford AM, Gauthier NS, Headrick JP. Transgenic A1 adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci U S A. 1997; 94(12): 6541-6546.
12. Kilpatrick EL, Narayan P, Mentzer RM Jr, Lasley RD. Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization. Am J Physiol Heart Circ Physiol. 2002; 282(3): H1035-H1040.
13. Lasley RD, Jahania MS, Mentzer RM Jr. Beneficial effects of adenosine A(2a) agonist CGS-21680 in infarcted and stunned porcine myocardium. Am J Physiol Heart Circ Physiol. 2001; 280(4): H1660-H1666.
14. Monahan TS, Sawmiller DR, Fenton RA, Dobson JG Jr. Adenosine A(2a)-receptor activation increases contractility in isolated perfused hearts. Am J Physiol Heart Circ Physiol. 2000; 279(4): H1472-H1481.
15. Shryock J, Song Y, Wang D, Baker SP, Olsson RA, Belardinelli L. Selective A2-adenosine receptor agonists do not alter action potential duration, twitch shortening, or cAMP accumulation in guinea pig, rat, or rabbit isolated ventricular myocytes. Circ Res. 1993; 72(1): 194-205.
16. Headrick JP, Hack B, Ashton KJ. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol. 2003; 285(5): H1797-H1818.
17. Sanbe A, Gulick J, Hanks MC, Liang Q, Osinska H, Robbins J. Reengineering inducible cardiacspecific transgenesis with an attenuated myosin heavy chain promoter. Circ Res. 2003; 92(6): 609-616.
18. Funakoshi H, Kubota T, Kawamura N, Machida Y, Feldman AM, Tsutsui H, Shimokawa H, Takeshita A. Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circ Res. 2002; 90(9): 959-965.
19. Funakoshi H, Kubota T, Machida Y, Kawamura N, Feldman AM, Tsutsui H, Shimokawa H, Takeshita A. Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol. 2002; 282(6): H2159-H2166.
20. Tucker AL, Song J, Zhang XQ, Wang J, Ahlers BA, Carl LL, Mounsey JP, Moorman JR, Rothblum LI, Cheung JY. Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: Role of Na+/Ca2 +exchange. Am J Physiol Heart Circ Physiol. 2006; 291(5): H2199-H2209.
21. Song J, Zhang XQ, Ahlers BA, Carl LL, Wang J, Rothblum LI, Stahl RC, Mounsey JP, Tucker AL, Moorman JR, Cheung JY. Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/ Ca2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol. 2005; 288(5): H2342-H2354.
22. Song J, Zhang XQ, Carl LL, Qureshi A, Rothblum LI, Cheung JY. Overexpression of phospholemman alters contractility and [Ca(2+)](i) transients in adult rat myocytes. Am J Physiol Heart Circ Physiol. 2002; 283(2): H576-H583.
23. Zhang XQ, Ng YC, Moore RL, Musch TI, Cheung JY. In situ SR function in postinfarction myocytes. J Appl Physiol. 1999; 87(6): 2143-2150.
24. Woodiwiss AJ, Honeyman TW, Fenton RA, Dobson JG Jr. Adenosine A2a-receptor activation enhances cardiomyocyte shortening via Ca2+-independent and -dependent mechanisms. Am J Physiol. 1999; 276(5 Pt 2): H1434-H1441.
25. Dobson JG Jr, Fenton RA. Adenosine A2 receptor function in rat ventricular myocytes. Cardiovasc Res. 1997; 34(2): 337-347.
26. Ahlers BA, Song J, Wang J, Zhang XQ, Carl LL, Tadros GM, Rothblum LI, Cheung JY. Effects of sarcoplasmic reticulum Ca2+-ATPase overexpression in postinfarction rat myocytes. J Appl Physiol. 2005; 98(6): 2169-2176.
27. Foerster K, Groner F, Matthes J, Koch WJ, Birnbaumer L, Herzig S. Cardioprotection specific for the G protein Gi2 in chronic adrenergic signaling through beta 2-adrenoceptors. Proc Natl Acad Sci U S A. 2003; 100(24): 14475-14480.
28. Gaudin C, Ishikawa Y, Wight DC, Mahdavi V, Nadal-Ginard B, Wagner TE, Vatner DE, Homcy CJ. Overexpression of Gs alpha protein in the hearts of transgenic mice. J Clin Invest. 1995; 95(4): 1676-1683.
29. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol. 2006; 7(8): 589-600.